Search This Blog

Monday, March 4, 2019

Biogen to buy Nightstar Therapeutics for about $800M

Biogen Inc said on Monday it will buy Nightstar Therapeutics Plc for about $800 million in cash.
Biogen’s offer of $25.50 per share, represents a premium of 68 percent to Nightstar’s Friday close of $15.16.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)